Oklahoma Medicaid program to receive $700,000 from pharmaceutical company

Published: July 30, 2013
Wyeth Pharmaceuticals has agreed to pay $491 million to resolve criminal and civil liability for the unlawful marketing of the prescription drug Rapamune.
Back to all NewsOK videos
Share on Facebook


If you prefer your thoughts to appear in The Oklahoman's Opinion section, we encourage you to submit a letter to the editor.

Recommend this on Facebook

Advertisement